<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04395040</url>
  </required_header>
  <id_info>
    <org_study_id>69HCL19_0731</org_study_id>
    <nct_id>NCT04395040</nct_id>
  </id_info>
  <brief_title>Identify the Obstacles to Early Diagnosis of Cancer in Patients Over 75 Years Old, on an Outpatient Basis</brief_title>
  <acronym>DPCMG</acronym>
  <official_title>Identify the Obstacles to Early Diagnosis of Cancer in Patients Over 75 Years Old, on an Outpatient Basis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A third of cancers are diagnosed in patients over 75 years of age. There are fears of the
      elderly talking about new symptoms. The doctor may find himself trapped by general symptoms,
      which can be confused with &quot;normal aging&quot;.

      Some older, younger people have lived in a world where cancer was little talked about, where
      there was little treatment possible.

      There is an idea that doctors are not very quick to start curative treatment because they
      think that the elderly cannot bear it.

      It is important to differentiate screening and early diagnosis.

      Delayed treatment causes a decrease in survival and quality of life. Cancer can be discovered
      suddenly: for example, occlusion with peritonitis in case of a stenosing colonic tumor,
      leading to urgent management.

      The elderly are often excluded from clinical studies.

      In addition, the geriatric population is heterogeneous, leading to very diverse and
      individual care, with prioritization of issues.

      Oncogeriatrics, which combines two services (oncology and geriatrics), is a specialized
      discipline, promoting comprehensive care for the elderly patient with cancer.

      The general practitioner is at the center of care. It detects early signs and starts
      examinations if necessary.

      Cancer care can be divided up with the different stages of care with various teams, including
      organ specialists.

      The general practitioner is the privileged interlocutor for the patient and their family
      (medico-psycho-social plan), who knows their history and their experience.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">June 2020</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Identify the obstacles to the early diagnosis of cancer in patients over 75 years old suffering from cancer.</measure>
    <time_frame>1 hour</time_frame>
    <description>Explore, during a semi-structured interview with the patient, the brakes and levers:
related to the patient
linked to the doctor: felt on the practices of health professionals, paternalistic, patient-centered approach
linked to the disease: symptoms, acceptance of examinations, acceptance of diagnosis
linked to society</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Cancer</condition>
  <condition>Aging</condition>
  <arm_group>
    <arm_group_label>Patients</arm_group_label>
    <description>Elderly patients with digestive cancer or breast cancer.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Semi-structured interview</intervention_name>
    <description>Semi-structured interview</description>
    <arm_group_label>Patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Elderly patients with digestive or breast cancer.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients over 75 years old (terminal included)

          -  Incident diagnosis

          -  Has cancer whose diagnosis dates back more than 3 months

          -  Digestive cancer, breast cancer

          -  Stage of advanced cancer (TNM stage: T&gt; T2 (terminal included), M1)

          -  According to the opinion of the oncogeriatrician on the time of taking charge

          -  Follow-up of a geriatrics service, onco-geriatrics orientation

          -  Living in the Rhône department

          -  Non-opposition of the patient to the study

        Exclusion Criteria:

          -  Cancer diagnosis more than 6 months old

          -  Patient denies
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>75 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Camille TAZELMATI, MD Student</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospices Civils de Lyon</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marie VALERO, MD</last_name>
    <role>Study Director</role>
    <affiliation>Hospices Civils de Lyon</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Camille TAZELMATI, MD Student</last_name>
    <phone>0620101366</phone>
    <phone_ext>+33</phone_ext>
    <email>camille.tazelmati@etu.univ-lyon1.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marie VALERO, MD</last_name>
    <phone>04 78 86 15 80</phone>
    <phone_ext>+33</phone_ext>
    <email>marie.valero@chu-lyon.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre Léon Bérard</name>
      <address>
        <city>Lyon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Catherine TERRET, MD</last_name>
    </contact>
    <investigator>
      <last_name>Catherine TERRET, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Lyon Sud</name>
      <address>
        <city>Pierre-Bénite</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Camille TAZELMATI, MD Student</last_name>
      <phone>0620101366</phone>
      <phone_ext>+33</phone_ext>
      <email>camille.tazelmati@etu.univ-lyon1.fr</email>
    </contact>
    <contact_backup>
      <last_name>Marie VALERO, MD</last_name>
      <phone>04 78 86 15 80</phone>
      <phone_ext>+33</phone_ext>
      <email>marie.valero@chu-lyon.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Camille TAZELMATI, MD Student</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marie VALERO, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Claire FALANDRY, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gilles ALBRAND, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre hospitalier Fleyriat</name>
      <address>
        <city>Viriat</city>
        <zip>01440</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jean-Robert LAMBERT, MD</last_name>
    </contact>
    <investigator>
      <last_name>Jean-Robert LAMBERT, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre hospitalier Fleyriat</name>
      <address>
        <city>Viriat</city>
        <zip>01440</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hubert ORFEUVRE, MD</last_name>
    </contact>
    <investigator>
      <last_name>Hubert ORFEUVRE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 15, 2020</study_first_submitted>
  <study_first_submitted_qc>May 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 20, 2020</study_first_posted>
  <last_update_submitted>May 15, 2020</last_update_submitted>
  <last_update_submitted_qc>May 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

